Verbanck JJ et al. |
Campylobacter jejuni II peritonitis in a CCPD patient: cure by oral clarithromycin. |
1999 Jan-Feb |
Perit Dial Int |
pmid:10201350
|
Sonnenberg A et al. |
The effect of antibiotic therapy on bleeding from duodenal ulcer. |
1999 |
Am. J. Gastroenterol. |
pmid:10201462
|
Smoot DT et al. |
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10201463
|
Laine L et al. |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. |
1999 |
Am. J. Gastroenterol. |
pmid:10201465
|
Zhou Q et al. |
CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin. |
1999 |
Eur. J. Clin. Pharmacol. |
pmid:10206083
|
Miwa H et al. |
Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10207779
|
Henry DC et al. |
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group. |
1999 |
Clin Ther |
pmid:10211537
|
McConnell SA and Amsden GW |
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. |
1999 |
Pharmacotherapy |
pmid:10212011
|
Dubois J and St-Pierre C |
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. |
1999 |
Diagn. Microbiol. Infect. Dis. |
pmid:10212753
|
Clifford K et al. |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. |
1999 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10214783
|
Kashimura H et al. |
Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215732
|
Lee JM et al. |
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215733
|
Neville PM et al. |
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215734
|
Hoffman JS et al. |
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215735
|
Abbott GW et al. |
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. |
1999 |
Cell |
pmid:10219239
|
van der Hulst RW et al. |
[Treatment of Helicobacter pylori infections]. |
1999 |
Ned Tijdschr Geneeskd |
pmid:10221109
|
Khan AA et al. |
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10221415
|
Sato K and Tomioka H |
Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells. |
1999 |
J. Antimicrob. Chemother. |
pmid:10223590
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Fish DN and Abraham E |
Pharmacokinetics of a clarithromycin suspension administered via nasogastric tube to seriously ill patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223952
|